Second-quarter 2011 IBO Life Science Index sales grew 8.6%, 5.6% excluding currency, to $3,191.57 million. Operating profit improved 9.8% to $703.35 million, but operating margin declined 200 basis points to 20.8% of sales. Fiscal third-quarter revenue for Becton Dickinson BD Biosciences division improved 9.3%, 4.3% excluding currency, to $337.9 million to make up 17% of […]
Overall, it was a solid calendar-year second quarter for major, US, publicly held analytical instrument companies. However, the continued slowdown in US academic spending raised concerns. Life Technologies and Waters each reported softer-than-expected results, citing delayed US academic and government spending. The eight businesses whose results are profiled on pages 9–11 reported combined sales growth […]
Reminiscent of a year ago, August proved to be a depressed month for global equity prices. Spurred by increased economic fears, the Dow Jones Industrial Average, S&P 500 and NASDAQ fell 4.4%, 5.7% and 6.4% for the month, respectively. Year to date, the Dow has gained 0.3%, while the S&P 500 and NASDAQ are down […]
Company Announcements In April, Metrohm became the exclusive distributor of Analytik Jena’s analytical measurement products in India and Scandinavia. In May, Anton Paar opened its 14th foreign subsidiary in Malmö, Sweden, to serve Sweden, Denmark and Finland. In June, Corning hired Dr. Richard Eglen as vice president and general manager of its Life Sciences business. […]
In the second quarter of 2011, revenues for IBO’s Laboratory Sales Index grew 12.2% to $5,659.71 million, including 3.9% growth from currency. Operating profit rose 15.0% to $1,131.55 million, but operating margin was unchanged at 18.9% of sales. Dionex was removed from the Index following its purchase by Thermo Fisher Scientific on May 17 (see […]
This spring, the National People’s Congress approved China’s 12th Five-Year Plan for 2011 to 2015. China’s five-year plans set the country’s economic and social priorities during the period. China is one of the fastest-growing markets for analytical and life science instrumentation. The goals of the Plan emphasize many of the same sectors that have fueled […]
The Dow Jones Industrial Average, S&P 500 and NASDAQ fell 2.2%, 2.1% and 0.6% in July. Wall Street’s anxiety was elevated due to political gridlock over how to raise the debt ceiling and the possibilities of a US Treasury credit downgrade. Economic data did little to mitigate the downward pressure as durable goods orders and […]
In January, when IBO issued its industry forecast for 2011 (see IBO 1/15/11), we were just coming off a year of robust growth and a sense of euphoria. The question was: could we keep up the momentum? Of course, we thought. Early in the year, without the benefit of fourth-quarter results from the previous year, […]
Company Announcements In May, Bruker opened a new Singapore Center of Excellence, which provides sales and after-sales services for Southeast Asia. The Center has a staff of 45 and expects to hire 10 to 20 more employees. Bruker opened in May a major applications, training and service center in Shanghai, China. The center brings together […]
R&D spending bounced back last year following the recession. In 2010, total R&D spending in US dollars for 18 major publicly held analytical and life science instrument and laboratory product companies grew 11.3% to $1.54 billion, compared with 2.3% growth for the same companies in 2009. R&D spending for these companies was accelerated by higher […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
